| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| imetelstat | telomerase reverse transcriptase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Primary Myelofibrosis[MeSHID:D055728] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocythemia Essential[MeSHID:D013920] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant neoplasm of breast[MeSHID:D001943] |
8.68 | phase 2/3 | inhibitor |
| imetelstat | telomerase reverse transcriptase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Primary Myelofibrosis[MeSHID:D055728] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Thrombocythemia Essential[MeSHID:D013920] Non-Small Cell Lung Carcinoma[MeSHID:D002289] Malignant neoplasm of breast[MeSHID:D001943] |
8.68 | phase 2/3 | unknown |
| click here to return to the previous page | ||||||||